Home / Products / Cancer (Tumor) Cell Lines / MFE-296
MFE-296
Datasheet Protocol

MFE-296

Cat. No. ARC0513
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Uterus (endometrium)

Growth Properties:

Adherent

In stock
$2,300.00 / Vial
Ask a Question

Short Description 🔒

MFE-296 is a cancer cell line of uterus (endometrium) adenocarcinoma, isolated from in situ; endometrium.

Recommended Products

LDHB Knockout NCI-H1299 Polyclonal Cells LDHB Knockout NCI-H1299 Polyclonal Cells Cat. No. ARG18078 GALNS Knockout Hela Polyclonal Cells GALNS Knockout Hela Polyclonal Cells Cat. No. ARG8445 ICAM1 Knockout A2780 Polyclonal Cells ICAM1 Knockout A2780 Polyclonal Cells Cat. No. ARG29173 HSPB1 Knockout HCT116 Polyclonal Cells HSPB1 Knockout HCT116 Polyclonal Cells Cat. No. ARG34797 ABHD6 Knockout CAL27 Polyclonal Cells ABHD6 Knockout CAL27 Polyclonal Cells Cat. No. ARG35830 C7orf50 Knockout MES-OV Polyclonal Cells C7orf50 Knockout MES-OV Polyclonal Cells Cat. No. ARG41552
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Uterus (endometrium)
Disease:
Adenocarcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
68 years
Sex of Donor:
Female
Derived From Site:
In situ; Endometrium
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

HDAC1 Knockout Jurkat Polyclonal Cells

HDAC1 Knockout Jurkat Polyclonal Cells

Cat. No. ARG23366
 ACBD5 Knockout NCI-H1299 Polyclonal Cells

ACBD5 Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG30207
 CASP6 Knockout TE1 Polyclonal Cells

CASP6 Knockout TE1 Polyclonal Cells

Cat. No. ARG42500
 C8orf33 Knockout HEK293T Polyclonal Cells

C8orf33 Knockout HEK293T Polyclonal Cells

Cat. No. ARG41565
 ABI2 Knockout huh-7 Polyclonal Cells

ABI2 Knockout huh-7 Polyclonal Cells

Cat. No. ARG27755
 MSH3 Knockout 786-O Polyclonal Cells

MSH3 Knockout 786-O Polyclonal Cells

Cat. No. ARG5435